A Form 4 filed on September 11, 2026 discloses that Charles Edwin Collins IV, Chief Executive Officer of Gemma at Argan, Inc. (NYSE:AGX), was granted 3,506 Time-Based Restricted Stock Units on September 9, 2026.

Key Highlights

  • Grant date: September 9, 2026, covering 3,506 shares of Argan, Inc. common stock.
  • Security type: Time-Based Restricted Stock Units (TRSUs) with a conversion price of $0.
  • Vesting schedule: The TRSUs will vest fully on September 9, 2029, according to the filing.
  • Post-transaction holdings: Collins beneficially owns 6,404 derivative securities following the reported transaction.
  • Reporting person role: Collins is identified as Chief Executive Officer, Gemma, and filed as an officer of the issuer.

TRSU Grant Details for Argan's Gemma CEO Charles Collins IV

According to the Form 4 filed with the U.S. Securities and Exchange Commission, Charles Edwin Collins IV, whose address is listed care of Argan, Inc. at 4075 Wilson Blvd, Suite 440, Arlington, Virginia, received a grant of 3,506 Time-Based Restricted Stock Units on September 9, 2026. The filing identifies Collins as an officer of Argan, Inc. (NYSE:AGX) with the title Chief Executive Officer, Gemma. The transaction was coded "A," indicating an acquisition of derivative securities.

The filing states that the TRSUs carry a conversion or exercise price of $0 and that the underlying security is Argan, Inc. common stock, with 3,506 shares underlying the grant. The TRSUs are reported as directly owned. Per the explanation of responses in the filing, "the TRSUs will vest fully on September 9, 2029," representing a three-year cliff vesting period from the grant date.

Following this transaction, the filing reports that Collins beneficially owns 6,404 derivative securities in total. No non-derivative securities transactions were reported in Table I of this filing. The Form 4 was signed by Charles E. Collins IV and dated September 11, 2026.

What Was Disclosed

The filing discloses a grant of 3,506 TRSUs to Argan, Inc.'s Gemma CEO on September 9, 2026, with full vesting scheduled for September 9, 2029, bringing his total beneficial derivative holdings to 6,404 units.